• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
OCUL

OCUL

Ocular Therapeutix, Inc.

NASDAQHealthcareBiotechnologyUS

USD8.35

+0.04 (+0.48%)

Rating:C-

Company Profile

CEO

Pravin U. Dugel

IPO Date

2014-07-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$8.19

Prev. Close

$8.31

Day Low

$8.12

Day High

$8.36

52W Low

$6.23

52W High

$16.44

Market Cap

$1.83B

Volume

2.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.4%

Avg Negative

4.0%

Avg Neutral

58.8%

News Feed

After Plunging 19.8% in 4 Weeks, Here's Why the Trend Might Reverse for Ocular Therapeutix (OCUL)

Zacks Investment Research·7/27/2021·↑ positive

Ocular Therapeutix™ To Present Clinical Data at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Business Wire·7/23/2021·↑ positive

Ocular Therapeutix: Catalysts Stacking

Seeking Alpha·5/6/2021
·↑ positive

Ocular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

CORRECTING and REPLACING Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Business Wire·5/3/2021·↑ positive

OCUL Stock: From $15.61 To Over $18 Explanation

Pulse2·4/29/2021·↑ positive

Ocular Therapeutix: Good Medicine, High Competition

Seeking Alpha·4/22/2021·↑ positive

Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/11/2021·↓ negative

Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research·3/11/2021·↑ positive

Will Ocular Therapeutix (OCUL) Report Negative Earnings Next Week? What You Should Know

Zacks Investment Research·3/4/2021·↑ positive